Cargando…
Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest of all major cancers. We now know that a ‘one-size-fits-all’ approach when treating PDAC patients does not work, so research has focused on developing personalised treatment strategies based on the biology of each patien...
Autores principales: | Kokkinos, John, Jensen, Anya, Sharbeen, George, McCarroll, Joshua A., Goldstein, David, Haghighi, Koroush S., Phillips, Phoebe A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156664/ https://www.ncbi.nlm.nih.gov/pubmed/34067833 http://dx.doi.org/10.3390/cancers13102427 |
Ejemplares similares
-
Exploiting Base Excision Repair to Improve Therapeutic Approaches for Pancreatic Cancer
por: Sharbeen, George, et al.
Publicado: (2015) -
Ex vivo culture of intact human patient derived pancreatic tumour tissue
por: Kokkinos, John, et al.
Publicado: (2021) -
Role of pancreatic stellate cells in chemoresistance in pancreatic cancer
por: McCarroll, Joshua A., et al.
Publicado: (2014) -
MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity
por: Sharbeen, George, et al.
Publicado: (2016) -
Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids()()
por: Sharbeen, G., et al.
Publicado: (2016)